Clinical trial

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

NCT02237937

Study summary

ClinicalTrials.gov

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication According to the ABCB1 Gene

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

9 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Paroxetine Normalized identity: paroxetine View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Sertraline Normalized identity: sertraline View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Citalopram Normalized identity: citalopram View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Venlafaxine Normalized identity: venlafaxine View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Amitriptyline Normalized identity: amitriptyline View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Escitalopram Normalized identity: escitalopram View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Amitriptylinoxide Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Nortriptyline Normalized identity: nortriptyline View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Trimipramine Normalized identity: trimipramine View linked drug · Find medicine records · Find other trials using this name

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE4

Conditions

Major Depressionverified · MONDO: major depressive disorder

Interventions

ParoxetineDRUG · verified · RxNorm: paroxetine

SertralineDRUG · verified · RxNorm: sertraline

CitalopramDRUG · verified · RxNorm: citalopram

VenlafaxineDRUG · verified · RxNorm: venlafaxine

AmitriptylineDRUG · verified · RxNorm: amitriptyline

EscitalopramDRUG · verified · RxNorm: escitalopram

AmitriptylinoxideDRUG

NortriptylineDRUG · verified · RxNorm: nortriptyline

TrimipramineDRUG · verified · RxNorm: trimipramine

Sponsors & collaborators

HolsboerMaschmeyer NeuroChemie GmbHlead sponsor

Max-Planck-Institute of Psychiatrycollaborator

Mapped research locations

MunichBavaria, Germany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02237937 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.